Skip to main content Accessibility help

Expression of Urotensin II During Focal Cerebral Ischemic in Diabetic Rats

  • Lin Tian (a1), Yunqian Li (a2), Wei Hua (a1), Ying Jia (a1), Min Zhou (a1), Yunhe Gu (a1) and Jiping Qi (a1)...



The objective of this study was to explore the expression of urotensin II (UII), its receptor (GPR14), and vascular endothelial growth factor (VEGF), as well as their associations in the ischaemic brains of rats with focal cerebral ischaemia, under normal and diabetic conditions.


Diabetes mellitus (DM) was induced by injection of streptozotocin (STZ) into Sprague—Dawley rats. Focal cerebral ischaemia was induced by middle cerebral artery occlusion (MCAO) four weeks after DM onset by STZ. Rats (n=80) were divided into four groups: normal control, DM, MCAO, and DM/MCAO. Immunohistochemistry and reverse-transcriptase-polymerase chain reaction (RT-PCR) were used to detect the expression of UII, GPR14 and VEGF in the diabetic and ischaemic brain.


Expression of UII and GPR14 was increased at mRNA and protein levels in the DM and MCAO group compared with controls. In the DM/MCAO group, expression of UII and GPR14 was increased significantly in the ischaemic brain, and was accompanied by a significantly increased VEGF expression.


Diabetes mellitus was seen to aggravate brain lesions after ischaemia, and UII may have an important role.

    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Expression of Urotensin II During Focal Cerebral Ischemic in Diabetic Rats
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Expression of Urotensin II During Focal Cerebral Ischemic in Diabetic Rats
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Expression of Urotensin II During Focal Cerebral Ischemic in Diabetic Rats
      Available formats


Corresponding author

Department of Pathology, the First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, PR China; Email:


Hide All
1.Berlind, A.Teleost caudal neurosecretory system: release of urotensin II from isolated urophyses. Gen Comp Endocrinol. 1972;18(3):557–60.
2.Ames, RS, Sarau, HM, Chambers, JK, et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature. 1999;401(6750):282–6.
3.Hirose, T, Takahashi, K, Mori, N, et al. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1. Peptides. 2009;30(6):1124–9.
4.Matsushita, M, Shichiri, M, Imai, T, et al. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens. 2001;19(12):2185–90.
5.Ong, KL, Wong, LY, Man, YB, et al. Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance. Peptides. 2006;27(7):1659–67.
6.Sidharta, PN, Wagner, FD, Bohnemeier, H, et al. Pharmacodynamics and pharmacokinetics of the urotensin II receptor antagonist palosuran in macroalbuminuric, diabetic patients. Clin Pharmacol Ther. 2006;80(3):246–56.
7.Totsune, K, Takahashi, K, Arihara, Z, et al. Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy. Peptides. 2004;25(10):1809–14.
8.Vogt, L, Chiurchiu, C, Chadha-Boreham, H, et al. Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathy. Hypertension. 2010;55(5):1206–9.
9.Dai, HY, Guo, XG, Ge, ZM, et al. Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy. J Diabetes Complications. 2008;22(2):137–43.
10.Dai, HY, Kang, WQ, Wang, X, et al. The involvement of transforming growth factor-beta1 secretion in urotensin II-induced collagen synthesis in neonatal cardiac fibroblasts. Regul Pept. 2007;140(1–2):8893.
11.Langham, RG, Kelly, DJ, Gow, RM, et al. Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy. Am J Kidney Dis. 2004;44(5):826–31.
12.Tzanidis, A, Hannan, RD, Thomas, WG, et al. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Circ Res. 2003;93(3):246–53.
13.Zhang, YG, Li, YG, Liu, BG, et al. Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol. Acta Pharmacol Sin. 2007;28(1):3643.
14.Davidson, EP, Coppey, LJ, Calcutt, NA, Oltman, CL, Yorek, MA.Diet-induced obesity in Sprague–Dawley rats causes microvascular and neural dysfunction. Diabetes Metab Res Rev. 2010;26(4):306–18.
15.Mellbin, LG, Malmberg, K, Waldenström, A, Wedel, H, Rydén, L, DIGAMI 2 investigators. Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial. Heart. 2009;95(9):721–7.
16.Jorgensen, HS, Nakayama, H, Raaschou, HO, Olsen, TS.Effect of blood pressure and diabetes on stroke in progression. Lancet. 1994;344(8916):156–9.
17.Bravata, DM, Kim, N, Concato, J, Brass, LM.Hyperglycaemia in patients with acute ischemic stroke: how often do we screen for undiagnosed diabetes? QJM. 2003;96(7):491–7.
18.Williams, LS, Rotich, J, Qi, R, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002;59(1):6771.
19.Badr, AE, Yin, W, Mychaskiw, G, Zhang, JH.Dual effect of HBO on cerebral infarction in MCAO rats. Am J Physiol Regul Integr Comp Physiol. 2001;280(3):R766–70.
20.Yin, D, Zhou, C, Kusaka, I, et al. Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. J Cereb Blood Flow Metab. 2003;23(7):855–64.
21.Bergeron, M, Yu, AY, Solway, KE, Semenza, GL, Sharp, FR.Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci. 1999;11(12):4159–70.
22.Martini, SR, Kent, TA.Hyperglycemia in acute ischemic stroke: a vascular perspective. J Cereb Blood Flow Metab. 2007;27(3):435–51.
23.Rossowski, WJ, Cheng, BJ, Taylor, JE, Datta, R, Coy, DH.Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinases; inhibition by somatostatin receptor antagonists. Eur J Pharmacol. 2002;438(3):159–70.
24.Gao, S, Oh, YB, Park, BM, Park, WH, Kim, SH.Urotensin, IIprotects ischemic reperfusion injury of hearts through ROS and antioxidant pathway. Peptides. 2012;36(2):199205.
25.Lindsberg, PJ, Roine, RO.Hyperglycemia in acute stroke. Stroke. 2004;35(2):363–4.
26.Capes, SE, Hunt, D, Malmberg, K, Pathak, P, Gerstein, HC.Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32(10):2426–32.
27.Ogunshola, OO, Stewart, WB, Mihalcik, V, Solli, T, Madri, JA, Ment, LR.Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res Dev Brain Res. 2000;119(1):139–53.
28.Ma, Y, Qu, Y, Fei, Z.Vascular endothelial growth factor in cerebral ischemia. J Neurosci Res. 2011;89(7):969–78.
29.Kanazawa, M, Igarashi, H, Kawamura, K, et al. Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment. J Cereb Blood Flow Metab. 2011;31(6):1461–74.
30.Yamamizu, K, Yamashita, JK.Roles of cyclic adenosine monophos phate signaling in endothelial cell differentiation and arterial-venous specification during vascular development. Circ J. 2011;75 (2):253–60.
31.Jin, X, Ge, X, Zhu, DL, et al. Expression and function of vascular endothelial growth factor receptors (Flt-1 and Flk-1) in vascular adventitial fibroblasts. J Mol Cell Cardiol. 2007;43(3):292300.
32.Pan, P, Fu, H, Zhang, L, et al. Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells. BMC Cell Biol. 2010;11:36.
33.Lacza, Z, W Busija, D., Urotensin-II is a nitric oxide-dependent vasodilator in the pial arteries of the newborn pig. Life Sci. 2006;78(23):2763–6.
34.Iglewski, M, Grant, SR.Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells. Vasc Health Risk Manag. 2010;6:723–34.
35.Zhang, YG, Li, J, Li, YG, Wei, RH.Urotensin II induces phenotypic differentiation, migration and collagen synthesis of adventitial fibro-blasts from rat aorta. J Hypertens. 2008;26(6):1119–26.
36.Song, N, Ding, W, Chu, S, et al. Urotensin II stimulates vascular endothelial growth factor secretion from adventitial fibroblasts in synergy with angiotensin II. Circ J. 2012;76(5):1267–73.
37.Sartore, S, Chiavegato, A, Faffin, E, et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: From innocent bystander to active participant. Cir Res. 2011;89(12): 1111–21.
38.Chuquet, J, Lecrux, C, Chatenet, D, et al. Effects of urotensin-II on cerebral blood flow and ischemia in anesthetized rats. Exp Neurol. 2008;210(2):577–84.


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed